Advertisement
Screener

EXICURE, INC. (XCUR) Deferred Tax Assets, Operating Loss Carryforwards

1.6 / 5 stars · 20/63 Roast Me

EXICURE, INC. Deferred Tax Assets, Operating Loss Carryforwards

EXICURE, INC. (XCUR) had Deferred Tax Assets, Operating Loss Carryforwards of $6.09 million as of 2025-12-31, per its 10-K filed 2026-03-25.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-25

  • 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.09M.
  • 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.96M.
  • 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.15M.
  • 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $36.33M.
Period endDeferred Tax Assets, Operating Loss Carryforwards
2025-12-31$6.09M
10-K · filed 2026-03-25
2024-12-31$3.96M
10-K · filed 2026-03-25
2023-12-31$3.15M
10-K · filed 2025-03-18
2022-12-31$36.33M
10-K · filed 2024-06-06
2021-12-31$42.77M
10-K · filed 2023-03-27
2020-12-31$26.35M
10-K · filed 2022-03-25
2019-12-31$22.34M
10-K · filed 2021-03-11
2018-12-31$14.83M
10-K · filed 2020-03-10
2017-12-31$8.75M
10-K/A · filed 2019-09-23
2016-12-31$8.11M
10-K · filed 2018-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
SOLIGENIX, INC. (SNGX)United States$0.008B
Imunon, Inc. (IMNN)United States$0.008B-0.56
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27